• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: I.V. TUBING; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

I.V. TUBING; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Device Problem Obstruction of Flow (2423)
Patient Problem Insufficient Information (4580)
Event Type  Injury  
Event Description
Spontaneous.(b)(6) medical center reports patient is admitted for unspecified iv line issues; pump was alarming for blockage detected.Unknown if patient was admitted late last night (b)(6) 2023 or this morning (b)(6) 2023.No further information, details or dates available.Iv remodulin pt.Pt is actively taking remodulin and opsumit.Reported to cvs/caremark by health professional.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
I.V. TUBING
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
MDR Report Key17086410
MDR Text Key316880377
Report NumberMW5118268
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/07/2023
Patient Sequence Number1
Treatment
OPSUMIT 10 MG, MFR: JNJ; PUMP; REMODULIN
Patient Outcome(s) Hospitalization;
Patient SexFemale
-
-